Skip to Content

The five-year-old Pacific trial on stage lll Non-small-cell cancer still reveals new findings.

In this MEDtalk the Chief Scientific Officer from Sarah Cannon research institute, David Speigel gives you the latest results from the five-year-old trial, that show a significant reduction in survival rates for patients.

David R. Spigel

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top